An Investigator-Initiated, Assessor Blinded, Randomized Study Comparing the Mechanism of Action of Adalimumab to Methotrexate in Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms MOA
- 10 Jun 2017 Biomarkers information updated
- 22 Jun 2016 Planned End Date changed from 1 Jun 2014 to 1 Jun 2017.
- 17 Sep 2013 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.